References
- Wenger JD, Ward JI. Haemophilus influenzae vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: WB Saunders Co, 2004:229-68
- American Academy of Pediatrics, Haemophilus influenzae infections. In: Pickering LK, editor. 2003 Red book: Report of the committee on infectious diseases. 26th ed. Elk Grove Village, 2003:293-301
- Santosham M, Wolff M, Reid R, Wolff M, Reid R, Hohenboken M, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outermembrane protein complex. N Engl J Med 1991;324:1767-72 https://doi.org/10.1056/NEJM199106203242503
- Harrison LH, Tajkowski C, Croll J, Reid R, Hu D, Brenneman G, et al. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children. J Pediatr 1994;125:571-6 https://doi.org/10.1016/S0022-3476(94)70009-5
- Black SB, Shinefield HR Fireman B, Hiatt R, Polen M, Vittinghoff E, The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr Infect Dis J 1991;10:97-104 https://doi.org/10.1097/00006454-199102000-00004
- Fritzell B, Plotkin S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J Pediatr 1992;121:355-62 https://doi.org/10.1016/S0022-3476(05)81786-X
- Booy R, Hodgson S, Carpenter L, Mayon-White RT, Slack MP, Macfarlane JA, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994;344: 362-6 https://doi.org/10.1016/S0140-6736(94)91400-1
- Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100 https://doi.org/10.1093/infdis/147.6.1100
- Anderson P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1984;149:1034-5
- Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990;135:121-8 https://doi.org/10.1016/0022-1759(90)90264-V
- Mathews DE, Farewell VT. Using and understanding medical statistics, 2nd ed. Basel: Karger AG, 1988:178
- Madore DV, Anderson P, Baxter BD, Carlone GM, Edwards KM, Hamilton RG, et al. Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 1996;3:84-8
- Kemeny DM, Challacombe SJ. ELISA and other solid phase immunoassays. Theoretical and practical aspects. New York: John Wiley & Sons Ltd. 1988:57-84
- Siber GR. Methods for estimating serological correlates of protection. Dev Biol Stand 1997;89:283-96
- Robbins JB, Schneerson R, Szu SC. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J Infect Dis 1995;171:1387-98? https://doi.org/10.1093/infdis/171.6.1387
- Fothergill LD, Wright J. Influenzal meningitis: the regulation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933;24:273-84
- Farr RS. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis 1958;103:239-62 https://doi.org/10.1093/infdis/103.3.239
- Ward JI, Greenberg DP, Anderson PW, Burkart KS, Christenson PD, Gordon LK, et al. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol 1988;26:72-8
- Barra A, Schulz D, Aucouturier P, Preud'homme JL. Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA. J Immunol Methods 1988;115:111-7 https://doi.org/10.1016/0022-1759(88)90317-1
- Kayhty H, Makela O, Eskola J, Saarinen L, Seppala I. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J Infect Dis 1988;158: 973-82 https://doi.org/10.1093/infdis/158.5.973
- Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 2003;10:514-9
- Guidance for Industry, Bioanalytical Method Validation. Drug Information Branch (HFD-210) Center for Drug Evaluation and Research (CDER). 2001 May. Available from: http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm
- Schmitt HJ, Zepp F, Muschenborn S, Sumenicht G, Schuind A, Beutel K, et al. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Eur J Pediatr 1998;157:208-14 https://doi.org/10.1007/s004310050797
- Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, et al. Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/ purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, fourand six-month-old infants. Pediatr Infect Dis J 1997;16: 863-70 https://doi.org/10.1097/00006454-199709000-00009
- Nolan T, Altmann A, Skeljo M, Streeton C, Schuerman L. Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. Vaccine 2004;23:14-20 https://doi.org/10.1016/j.vaccine.2004.06.017
- Amir J, Liang X, Granoff DM. Variability in the functional activity of vaccines induced antibody to Haemophilus influenzae type b. Pediatr Res 1990;27:358-64 https://doi.org/10.1203/00006450-199004000-00008
- Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998;177:1112-5 https://doi.org/10.1086/517407
- Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Feris J, Balter S, et al. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate). Clin Diagn Lab Immunol 2001;8:1115-9